Esperion Therapeutics
Daniel Gass has a diverse work experience spanning over several years. Daniel is currently working as the Executive Director - Pricing, Contracting & Trade at Esperion since March 2022. Prior to this, they held the role of Senior Director - Pricing & Contracting Strategy from May 2021 to April 2022 at the same company.
Before joining Esperion, Daniel worked at Bristol Myers Squibb as an Associate Director - Contract Strategy and Pricing from March 2020 to May 2021. Daniel also worked at Celgene as an Associate Director - Contracting and Pricing from June 2017 to March 2020.
Earlier in their career, Daniel served at Express Scripts as a Senior Manager, Pharmaceutical Strategies & Contracting from July 2011 to June 2017. Prior to that, they worked as a Financial Analyst at Medco from June 2008 to August 2011.
Daniel's professional journey began at Avis Budget Group, where they worked as a Pricing Analyst from October 2007 to June 2008. Daniel also briefly worked as a Sourcing Coordinator at Robert Half Finance & Accounting in 2007.
Daniel Gass has a Bachelor of Science degree in Finance/Management from the University at Albany, SUNY. The start and end years of their education are not specified.
This person is not in any offices
Esperion Therapeutics
2 followers
Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at ESPERION is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.